AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prednisone for CRPS in Distal Radius Fracture

RecruitingNAAges 19 Years - anyAllUniversity of British Columbia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Wrist fractures are the most prevalent adult fracture. Complex regional pain syndrome (CRPS) is a common complication that can occur, leading to permanent disability and is costly to the patient and healthcare system. In addition, amidst the opioid epidemic, the risk of increased opioid use in patients with CRPS prompts the need to find viable treatment strategies. This study aims to evaluate an anti-inflammatory medication, prednisone, in the early treatment of CRPS. Patients with wrist fractures who undergo surgical treatment will be randomized to receiving placebo vs prednisone for 2 weeks. Clinical assessments in the follow up period will be compared.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient is aged 19 years or older; 2. Patient has a unilateral, closed, distal radius fracture confirmed by radiographs; 3. The fracture is acute, within 21 days of injury; 4. Patient undergoes open reduction internal fixation with volar locking plate; 5. Patient is identified as at risk of developing CRPS with 2 or more of the following: 1. Pain score on visual analogue scale (VAS) greater than or equal to 5/10 within 1 week of injury and beyond; 2. Centre of Epidemiologic Studies Depression (CES-D) score on presentation is greater than or equal to 16; 3. Patient identifies as female; 6. Patient is identified as developing signs of CRPS based on the Budapest CRPS Criteria; 7. Patient provides informed consent. Exclusion Criteria: 1. Patient has previously fractured ipsilateral wrist; 2. Patient has neurovascular injury associated with distal radius fracture; 3. Patient has associated extremity or polytrauma injuries that would interfere with rehabilitation and outcome measurements, in the opinion of the investigator; 4. Patient has allergy to prednisone or placebo ingredients; 5. Patient has contraindication to prednisone or placebo ingredients; 6. Patient already takes a glucocorticoid medication; 7. Patient has active bacterial, viral, or fungal infection; 8. Patient is diagnosed with diabetes; 9. Patient is pregnant, planning on becoming pregnant, or breastfeeding; 10. Patient is anticipated to have difficulty completing study follow up, in the opinion of the investigator.
๐Ÿ’Š

What it tests

  • Prednisone
  • Placebo
๐Ÿ“

Where

1 site
Vancouver General Hospital
Vancouver, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy